Riskpilot← Back to searchSign inGet full accessSOLLI KLINIKK AS
ASActiveOrg 979496168Saggata 3, 2053 JessheimGeneral medical practice activities · NACE 8621Est. 19977 employees
Revenue 2025
NOK 6,6M
+5% vs 2024
EBITDA margin
8.3%
-25% vs 2024
Equity ratio
30.8%
Financial strength
Net profit 2025
NOK 369K
-24% vs 2024
| Revenue | NOK 6,6M | +5% |
| EBITDA | NOK 550K | -25% |
| Net profit | NOK 369K | -24% |
| Total assets | NOK 1,8M | -11% |
| Equity | NOK 569K | -29% |
| Employees | 7 | — |
Legal name
SOLLI KLINIKK AS
Org number
979496168
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
3. desember 1997
Share capital
NOK 366 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Address
Saggata 3, 2053 Jessheim
Phone
+4763948550
Email
kristian.furuseth@solliklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 901 | 5 583 | 6 013 | 6 252 | 6 589 |
| Staff expenses | −2 077 | −2 395 | −2 319 | −2 335 | −2 673 |
| EBITDA | 1 148 | 167 | 685 | 738 | 550 |
| Depreciation & amort. | −156 | −143 | −115 | −127 | −95 |
| EBIT | 992 | 24 | 570 | 611 | 455 |
| Net financials | −1 | −0 | 2 | 13 | 19 |
| Profit before tax | 991 | 24 | 572 | 624 | 473 |
| Tax | 218 | 5 | 125 | 137 | 104 |
| Net profit | 773 | 19 | 447 | 486 | 369 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 260 | 1 657 | 2 333 | 2 072 | 1 848 |
| Equity | 1 048 | 1 066 | 913 | 800 | 569 |
| Long-term debt | 26 | 25 | 26 | 28 | 21 |
| Short-term debt | 1 186 | 566 | 1 393 | 1 245 | 1 258 |
| Total debt | 1 213 | 591 | 1 419 | 1 273 | 1 279 |
EBITDA margin
8.3%
This company
15.8%
Market median
-47% vs market
20212025
Equity ratio
30.8%
This company
38.2%
Market median
+19% vs market
20212025
Return on equity
64.9%
This company
18.4%
Market median
+253% vs market
20212025
Net profit margin
5.6%
This company
8.1%
Market median
-31% vs market
20212025
Asset turnover
3.57×
This company
1.12×
Market median
+219% vs market
20212025
Debt / equity
2.25×
This company
0.62×
Market median
-263% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Board of Directors | 2019 – 2023 | |
| Board of Directors | 2019 – 2024 | |
| Chairman | 2019 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SOLLI KLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stein Vaaler | Board of Directors | 0 companies |
| Lars Hansen | Board of Directors | 0 companies |
| Kristian Furuseth | Chairman | 0 companies |